Newspaper Publication of unaudited financial results for the quarter and nine months ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has filed copies of newspaper advertisements containing its unaudited financial results for the quarter and nine months ended December 31, 2025. The ads were published in Financial Express (English) and Nava Telangana (Telugu) on February 8, 2026. This is a standard regulatory compliance filing under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has also made the results available on its website at www.venmaxdrugs.com. The filing was signed by Whole Time Director Venkata Rao Sadhanala on February 9, 2026.
This is a routine procedural compliance filing with no new material information. No direct impact on shareholders or stock price is expected from this disclosure itself — the actual Q3 FY26 financial results would have been filed and disclosed separately with BSE earlier.